By , More than a hundred vaccines are under development to try and stop the COVID-19 pandemic, and drugmakers including J&J are working to ramp up supply for their vaccines in the face of unprecedented demand.J&J has already agreed to prioritize an allocation to the United States as part of its funding agreement with the U.S. government’s Biomedical Advanced Research and Development Authority (BARDA), Wolk said.The Bill and Melinda Gates Foundation would focus on allocating any vaccine it acquired to developing countries, Wolk added. Reuters previously reported that J&J is also...…By , More than a hundred vaccines are under development to try and stop the COVID-19 pandemic, and drugmakers including J&J are working to ramp up supply for their vaccines in the face of unprecedented demand.J&J has already agreed to prioritize an allocation to the United States as part of its funding agreement with the U.S. government’s Biomedical Advanced Research and Development Authority (BARDA), Wolk said.The Bill and Melinda Gates Foundation would focus on allocating any vaccine it acquired to developing countries, Wolk added. Reuters previously reported that J&J is also...WW…

By , (Reuters) - U.S. regulators on Friday said they would work quickly to authorize Johnson & Johnson’s COVID-19 vaccine for emergency use after a panel of outside advisers backed the one-shot immunization.The Food and Drug Administration is expected to decide on emergency use by Saturday for what would be the third vaccine available in the United States, and the only one that requires a single shot.The agency told J&J that “it will rapidly work toward finalization and issuance of an emergency use authorization,” the regulator said in a statement after the vote by advisers.“The...…By , (Reuters) - U.S. regulators on Friday said they would work quickly to authorize Johnson & Johnson’s COVID-19 vaccine for emergency use after a panel of outside advisers backed the one-shot immunization.The Food and Drug Administration is expected to decide on emergency use by Saturday for what would be the third vaccine available in the United States, and the only one that requires a single shot.The agency told J&J that “it will rapidly work toward finalization and issuance of an emergency use authorization,” the regulator said in a statement after the vote by advisers.“The...WW…

By (Reuters) - Making sure a mask fits snugly on the face and use of two masks is likely to significantly reduce a person’s exposure to the coronavirus, laboratory experiments described by U.S. health officials on Wednesday showed.The U.S. Centers of Disease Control and Prevention (CDC) in January conducted experiments to see how well wearing a cloth mask over a three-ply medical procedure mask, and knotting the ear loops of a surgical mask and then tucking the excess material close to the face, protects against COVID-19.They found that both these methods helped reduce the exposure to...…By (Reuters) - Making sure a mask fits snugly on the face and use of two masks is likely to significantly reduce a person’s exposure to the coronavirus, laboratory experiments described by U.S. health officials on Wednesday showed.The U.S. Centers of Disease Control and Prevention (CDC) in January conducted experiments to see how well wearing a cloth mask over a three-ply medical procedure mask, and knotting the ear loops of a surgical mask and then tucking the excess material close to the face, protects against COVID-19.They found that both these methods helped reduce the exposure to...WW…

By The United States and Moderna announced the agreement for 100 million doses of its potential COVID-19 vaccine late on Tuesday.The company’s vaccine candidate, mRNA-1273, is one of the few that have already advanced to the final stage of testing.The deal confirms Moderna’s experimental vaccine is one of the leading contenders, said BMO analyst George Farmer, who has an “outperform” rating on the stock.With the U.S. contract now signed, other deals could follow, said Jefferies analyst Michael Yee, who has a “buy” rating.“We assume other countries ... will want to secure deals out of sheer...…By The United States and Moderna announced the agreement for 100 million doses of its potential COVID-19 vaccine late on Tuesday.The company’s vaccine candidate, mRNA-1273, is one of the few that have already advanced to the final stage of testing.The deal confirms Moderna’s experimental vaccine is one of the leading contenders, said BMO analyst George Farmer, who has an “outperform” rating on the stock.With the U.S. contract now signed, other deals could follow, said Jefferies analyst Michael Yee, who has a “buy” rating.“We assume other countries ... will want to secure deals out of sheer...WW…

Read full articleBy Michael Erman and Manas Mishra(Reuters) - Pfizer Inc on Tuesday said other developed countries would not get a lower price for its coronavirus vaccine than what it will charge the United States under a contract announced last week, and suggested that people may need multiple vaccinations in order to remain protected.The U.S. government agreed to pay nearly $2 billion to buy enough of a COVID-19 vaccine being developed by Pfizer and German biotech BioNTech SE <22UAy.F> to inoculate 50 million people at a price of $39 for a two-dose treatment course."All the...…Read full articleBy Michael Erman and Manas Mishra(Reuters) - Pfizer Inc on Tuesday said other developed countries would not get a lower price for its coronavirus vaccine than what it will charge the United States under a contract announced last week, and suggested that people may need multiple vaccinations in order to remain protected.The U.S. government agreed to pay nearly $2 billion to buy enough of a COVID-19 vaccine being developed by Pfizer and German biotech BioNTech SE <22UAy.F> to inoculate 50 million people at a price of $39 for a two-dose treatment course."All the...WW…